StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Trade Payables by Quarter

Trade Payables ($M)

QuarterlyAnnual

Novartis Trade Payables: $4,243M in Q3 2026, down 6.8% from a year earlier.

Latest, Q3 2026
4,243
Period ended Sep 30, 2026
Change on a year earlier
-6.8%
4,555 in Q3 2025
History
32 quarters
Since Q4 2018
Sources
24
Documents cited below

Where the Q3 2026 figure comes from

“|| Trade payables | 4 243 | 4 456”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTrade Payables ($M)Year on yearSource
Q3 2026Sep 30, 20264,243-6.8%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20264,258-5.5%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20264,322+1.4%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20254,456-2.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q3 2025Sep 30, 20254,555+11.5%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 20254,506+8.7%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 20254,261+4.9%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 20244,572-7.2%Novartis Form 6-K (0001114448-25-000003) ↗
Q3 2024Sep 30, 20244,087+5.6%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 20244,146-22.5%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 20244,062-25.1%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 20234,926-4.3%Novartis Form 6-K (0001370368-24-000022) ↗
Q3 2023Sep 30, 20233,870-17.5%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 20235,350+7.7%Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 20235,426+6.7%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 20225,146-7.3%Novartis Form 6-K (0001370368-23-000068) ↗

Cite this data

StockData. (2026). Novartis Trade Payables ($M), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-ap

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.